Search research articles
Contact Us
Filters
Showing results (181-190 of 220) with videos related to
Page
of 22
Sort By:
Blood Advances
|
November 21, 2024
Chronic inflammation deters natural killer cell fitness and cytotoxicity in myeloid leukemia
Valeriya Kuznetsova, Vaidehi Krishnan, Amanda Costa, et al.
Blood
|
July 2, 2011
Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice
Simon F Lacey, Corinna La Rosa, Teodora Kaltcheva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2024
Sex-Based Differences in Risk of Therapy-Related Myeloid Neoplasms
Melissa A Richard, Chengcheng Yan, Yanjun Chen, et al.
Leukemia Research
|
June 9, 2012
Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis
Ryotaro Nakamura, Joycelynne M Palmer, Margaret R O'Donnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2022
Financial Burden in Blood or Marrow Transplantation Survivors During the COVID-19 Pandemic: A BMTSS Report
Smita Bhatia, Chen Dai, Lindsey Hageman, et al.
Blood
|
February 14, 2018
<i>hsa-mir183/EGR1</i>-mediated regulation of E2F1 is required for CML stem/progenitor cell survival
Francesca Pellicano, Laura Park, Lisa E M Hopcroft, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2025
Germline Pathogenic/Likely Pathogenic Mutations and Subsequent Neoplasms Among Childhood Cancer Survivors: A Report From the Children's Oncology Group ALTE03N1 Study
Liting Zhou, Purnima Singh, David Crossman, et al.
JAMA Oncology
|
September 9, 2021
Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report
Smita Bhatia, Chen Dai, Wendy Landier, et al.
Plos One
|
April 24, 2018
Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib
Marcus J G W Ladds, Andrés Pastor-Fernández, Gergana Popova, et al.
Blood
|
September 4, 2020
Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL
Yaqi Zhao, Ibrahim Aldoss, Chunxu Qu, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 220) with videos related to
Sort By:
Page
of 22
Blood Advances
|
November 21, 2024
Chronic inflammation deters natural killer cell fitness and cytotoxicity in myeloid leukemia
Valeriya Kuznetsova, Vaidehi Krishnan, Amanda Costa, et al.
Blood
|
July 2, 2011
Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice
Simon F Lacey, Corinna La Rosa, Teodora Kaltcheva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2024
Sex-Based Differences in Risk of Therapy-Related Myeloid Neoplasms
Melissa A Richard, Chengcheng Yan, Yanjun Chen, et al.
Leukemia Research
|
June 9, 2012
Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis
Ryotaro Nakamura, Joycelynne M Palmer, Margaret R O'Donnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2022
Financial Burden in Blood or Marrow Transplantation Survivors During the COVID-19 Pandemic: A BMTSS Report
Smita Bhatia, Chen Dai, Lindsey Hageman, et al.
Blood
|
February 14, 2018
<i>hsa-mir183/EGR1</i>-mediated regulation of E2F1 is required for CML stem/progenitor cell survival
Francesca Pellicano, Laura Park, Lisa E M Hopcroft, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2025
Germline Pathogenic/Likely Pathogenic Mutations and Subsequent Neoplasms Among Childhood Cancer Survivors: A Report From the Children's Oncology Group ALTE03N1 Study
Liting Zhou, Purnima Singh, David Crossman, et al.
JAMA Oncology
|
September 9, 2021
Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report
Smita Bhatia, Chen Dai, Wendy Landier, et al.
Plos One
|
April 24, 2018
Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib
Marcus J G W Ladds, Andrés Pastor-Fernández, Gergana Popova, et al.
Blood
|
September 4, 2020
Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL
Yaqi Zhao, Ibrahim Aldoss, Chunxu Qu, et al.
Page
of 22